Abiopharma

Combs Dustin 🔴 sold 3.4K shares (2 derivative) of WEYCO GROUP INC (WEYS) at $44.64 Transaction Date: Aug 27, 2026 | Filing ID: 000004

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025338 <b>Size:</b> 1 MB

New Form FWP - VanEck Merk Gold ETF <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001213900-26-094887 <b>Size:</b> 2 MB

New Form 424B2 - BANK OF NOVA SCOTIA <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001839882-26-042218 <b>Size:</b> 657 KB

New Form 8-K/A - YUM BRANDS INC <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001041061-26-000180 <b>Size:</b> 140 KB <br />Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Clinical trial NCT07746583 updates: 1. start date: 2026-08-07 → 2026-09-15 2. completion date: 2029-02-07 → 2029-03-15

Clinical trial NCT03145181: completion date: 2027-05-28 → 2027-08-24.

Clinical trial NCT06052631: start date: 2026-09-01 → 2026-09-02.

Clinical trial NCT05652335: completion date: 2028-08-28 → 2030-11-15.

Clinical trial NCT07537114: start date: 2026-08-01 → 2026-11-01.

Clinical trial NCT06771713: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT07348809: primary completion date: 2026-01-15 → 2024-11-02.

Clinical trial NCT06804785 updates: 1. status: RECRUITING → WITHDRAWN 2. enrollment: 800 → 0 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05957276 updates: 1. completion date: 2026-07-07 → 2026-07-02 2. enrollment: 887 → 886 participants

Clinical trial NCT07164443: primary completion date: 2027-12-29 → 2028-08-18.